Related Experiment Video
Updated: Jun 13, 2026

07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
[New data on pancreatic cancer].
Rainer Fietkau1, Volker Heinemann, Helmut Oettle
1Klinik für Strahlentherapie, Universitätsklinik Erlangen, Deutschland. rainer.fietkau@uk-erlangen.de
Onkologie
|May 1, 2010
Summary
Accurate R0 resection assessment is crucial for predicting pancreatic cancer outcomes. Improving histopathological standards and defining circumferential resection margins can enhance long-term survival for patients.
Area of Science:
- Oncology
- Surgical Pathology
- Gastroenterology
Context:
- Pancreatic cancer presents a significant discrepancy between reported R0 resection rates and actual long-term patient survival.
- Current R classification methods exhibit variability across studies, impacting prognostic accuracy.
- Vascular invasion, particularly portal vein or superior mesenteric vein infiltration, is often inadequately addressed surgically despite not being an exclusion criterion.
Purpose:
- To highlight the need for improved prognostic parameters beyond current R0 resection rates in pancreatic cancer.
- To advocate for standardized histopathological preparation and the adoption of a 'circumferential resection margin' similar to rectal cancer.
- To emphasize the importance of achieving specific tumor-free resection margins (>1.0 mm or >1.5 mm) for optimal long-term survival.
Summary:
- The study identifies inconsistencies in R classification and proposes enhanced histopathological evaluation, including circumferential resection margins, to better predict pancreatic cancer outcomes.
- Achieving a resection margin of >1.0 mm or >1.5 mm is crucial for optimal long-term survival.
- Recommendations include establishing high-volume pancreas centers and further investigating perioperative radiochemotherapy (RCT), while adjuvant chemotherapy remains a standard treatment.
Impact:
- Potential to improve the accuracy of prognostic assessments in pancreatic cancer surgery.
- Guidelines for histopathological evaluation and surgical margins may be refined, leading to better patient selection and outcomes.
- Centralization of care in high-volume centers and ongoing research into perioperative treatments could enhance overall treatment quality and survival rates.

